SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

State of the Union: Obama’s fast-track trade plans divide pharma

President Obama in his State of the Union address has called for the power to personally make stronger trade agreements – bringing divisive EU deal TTIP closer to adoption and angering campaigners for drugs access.

Barack Obama's State of the Union address divides pharma

BASF to take on Asian PVP producers and target generics firms with new capacity in China

BASF will spend €56m to increase production capacity for the excipient PVP by expanding existing plants and introducing manufacturing capabilities at its facility in Shanghai, China.

Pharma turning to injectable systems to protect biologics, says Unilife

Big Pharma firms like AbbVie are partnering with delivery device makers to guard against biosimilar competition according to Unilife CEO,  Alan Shortall.

Antibiotics "a terrible business model" for Pharmas expert tells Davos

Drug industry execs  at the World Economic Forum in Davos were told they are no longer best placed to develop antibiotics by a panel who said Governments should lead efforts to create these vital new drugs.

FDA's wearables guidance could slow pharma adoption in short-term, says analyst

Draft guidance distinguishing wearable medical devices from ‘general wellness’ devices could slow pharma’s adoption of such data in the short-term, according to an analyst.

Teva: More biomanufacturing space needed to tap biologics opportunities

Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman told investors.

Spotlight

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Regulatory enforcement saw fewer counterfeit drug websites in 2014 but sellers are turning to YouTube and social...

Resistance is…years away: New compound could delay post antibiotic era

Resistance is…years away: New compound could delay post antibiotic era

Discovering a new antibiotic candidate and finding out how it kills superbugs without letting resistant mutants escape...

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Falling oil prices will cut drug industry materials, manufacturing and logistics costs, and protect firms at risk...

Gilead strikes back at AbbVie with exclusive payer deal for hep C drug

US pharmacy deals could cut costs of AbbVie and Gilead's HCV treatments

Gilead and AbbVie’s exclusive deals with payers CVS and Express Scripts could help cut the cost of...

Not prepared for track & trace? US FDA grants amnesty until May

Not prepared for track & trace? US FDA grants amnesty until May

The US FDA will give drugmakers and distributors until May to comply with new track and trace...

Professional liaisons: ‘Tinder for healthcare’ shakes up conferences

Professional liaisons: ‘Tinder for healthcare’ shakes up conferences

Mobile software modelled on the dating app Tinder could help life science investors find new partners according...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Products